These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 8901158)
21. Bactericidal activity and post-antibiotic effect in vitro of dactimicin alone and in combination with other drugs. Debbia E; Schito GC; Stefani S; Nicoletti G J Chemother; 1989 Jul; 1(4 Suppl):187-8. PubMed ID: 16312361 [No Abstract] [Full Text] [Related]
22. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ; Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan. Ahmed AA; Osman H; Mansour AM; Musa HA; Ahmed AB; Karrar Z; Hassan HS Am J Trop Med Hyg; 2000; 63(5-6):259-63. PubMed ID: 11421374 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent. Fanaki NH; el-Nakeeb MA J Chemother; 1992 Dec; 4(6):347-52. PubMed ID: 1287137 [TBL] [Abstract][Full Text] [Related]
26. Comparative in-vitro antibacterial activity of two brands of antibiotics against clinical isolates of some bacterial genera. Odelola HA; Jaiyebo O; Anukam PA; Akanni AO Afr J Med Med Sci; 1989 Dec; 18(4):307-10. PubMed ID: 2558563 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp. Sader HS; Jones RN Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291 [TBL] [Abstract][Full Text] [Related]
28. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967 [TBL] [Abstract][Full Text] [Related]
29. In vitro synergy of ampicillin and chloramphenicol against gram-negative bacteria. Kaplan SL; Mason EO Pediatr Pharmacol (New York); 1981; 1(4):305-11. PubMed ID: 7346749 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic activity and synergistic effect of antimicrobial peptide against pathogens from a patient with gallstones. Park Y; Park SN; Park SC; Park JY; Park YH; Hahm JS; Hahm KS Biochem Biophys Res Commun; 2004 Aug; 321(3):631-7. PubMed ID: 15358153 [TBL] [Abstract][Full Text] [Related]
31. Antibacterial properties of traditionally used Indian medicinal plants. Aqil F; Ahmad I Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):79-92. PubMed ID: 17440624 [TBL] [Abstract][Full Text] [Related]
32. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections. Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961 [TBL] [Abstract][Full Text] [Related]
33. Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa. Moriarty F; Elborn S; Tunney M J Microbiol Methods; 2005 May; 61(2):171-9. PubMed ID: 15722142 [TBL] [Abstract][Full Text] [Related]
34. Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization. Kwakman PH; Van den Akker JP; Güçlü A; Aslami H; Binnekade JM; de Boer L; Boszhard L; Paulus F; Middelhoek P; te Velde AA; Vandenbroucke-Grauls CM; Schultz MJ; Zaat SA Clin Infect Dis; 2008 Jun; 46(11):1677-82. PubMed ID: 18433338 [TBL] [Abstract][Full Text] [Related]
35. Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases. Bonomo RA Clin Infect Dis; 2000 Dec; 31(6):1414-22. PubMed ID: 11096012 [TBL] [Abstract][Full Text] [Related]
36. Biological activity of an antibiotic produced by Myxococcus coralloides. Arias JM; Rodriguez C; Montoya E Microbios; 1979; 24(96):123-31. PubMed ID: 120482 [TBL] [Abstract][Full Text] [Related]
37. [Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002]. Shen XZ; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Jiang M; Hu YY; Yang YH Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1335-9. PubMed ID: 15387940 [TBL] [Abstract][Full Text] [Related]
38. Combining quinupristin/dalfopristin with other agents for resistant infections. Brown J; Freeman BB Ann Pharmacother; 2004 Apr; 38(4):677-85. PubMed ID: 14990776 [TBL] [Abstract][Full Text] [Related]
39. Synergistic antibacterial activity of the combination of the alkaloid sanguinarine with EDTA and the antibiotic streptomycin against multidrug resistant bacteria. Hamoud R; Reichling J; Wink M J Pharm Pharmacol; 2015 Feb; 67(2):264-73. PubMed ID: 25495516 [TBL] [Abstract][Full Text] [Related]
40. Drug resistant bacteria in non carbonated mineral waters. Massa S; Petruccioli M; Fanelli M; Gori L Microbiol Res; 1995 Nov; 150(4):403-8. PubMed ID: 8564367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]